Baricitinib Impurity 29(CAS: 1187595-90-9)

Baricitinib Impurity 29 (CAS: 1187595-90-9) is a byproduct found in the manufacturing process of baricitinib, a Janus kinase (JAK) inhibitor used for treating rheumatoid arthritis and certain types of pneumonia. It is a complex organic compound with a specific molecular structure that plays a minor role in the overall compound but is managed to ensure product quality and safety.

Baricitinib Impurity 29 (CAS: 1187595-90-9) is primarily managed and monitored during the synthesis process of baricitinib for pharmaceutical applications. It is not used independently but is important for ensuring the quality and purity of the final drug product.

Baricitinib Impurity 29 (CAS: 1187595-90-9) is generally considered safe when managed as a controlled byproduct during the production of baricitinib. However, it should be handled with appropriate safety measures, including the use of personal protective equipment (PPE) and proper ventilation.

Baricitinib Impurity 29 (CAS: 1187595-90-9) should be stored in a cool, dry place, away from direct sunlight and heat sources. It should be kept in a tightly sealed container to prevent degradation. Optimal storage conditions are typically between 2°C and 8°C (36°F to 46°F) to ensure stability and safety.